Prazosin vs Trazodone for PTSD-Related Nightmares
Prazosin is the preferred medication for treating PTSD-related nightmares with Level A evidence from the American Academy of Sleep Medicine, while trazodone has more limited supporting evidence. 1
First-Line Treatment Approach
Non-Pharmacological Options
- Image Rehearsal Therapy (IRT) should be attempted first before medication
- If IRT is insufficient after 4-6 weeks, pharmacological treatment should be added
Pharmacological Treatment
Prazosin (First-Line)
Dosing protocol:
- Start at 1 mg at bedtime
- Titrate by 1-2 mg every 3-7 days
- Target effective dose: 3 mg (range 1-10+ mg)
- Some patients may require higher doses (up to 30-45 mg in treatment-resistant cases)
- Consider twice-daily dosing for some patients 1
Efficacy:
Monitoring:
- Watch for orthostatic hypotension, especially after first dose
- Monitor blood pressure during treatment 1
Trazodone (Alternative Option)
Dosing:
Efficacy:
Side effects:
Clinical Decision Algorithm
- Start with non-pharmacological treatment (IRT)
- If IRT is insufficient after 4-6 weeks, add pharmacological treatment:
- First choice: Prazosin (start at 1 mg, titrate as needed)
- If prazosin is contraindicated or not tolerated: Consider trazodone
- If combined approach fails:
- Consider clonidine (0.1-0.6 mg) or atypical antipsychotics as adjunctive therapy 1
Important Considerations and Pitfalls
- Avoid underdosing prazosin - many patients require doses higher than initially prescribed
- Monitor for orthostatic hypotension with prazosin, especially after first dose
- Be vigilant about priapism with trazodone - directly ask male patients about this side effect
- Avoid medications specifically not recommended for nightmare disorder:
- Clonazepam (ineffective)
- Venlafaxine (not recommended) 1
- Don't rely solely on pharmacological treatment - combination with behavioral approaches is optimal
- Don't discontinue treatment prematurely - continued therapy may be necessary for sustained benefit
Prazosin demonstrates superior efficacy and safety profile compared to trazodone for PTSD-related nightmares, with stronger evidence supporting its use as first-line pharmacological treatment when medication is needed 1, 5.